Skip to main content
. 2019 Mar 11;100(5):1158–1163. doi: 10.4269/ajtmh.17-0341

Table 2.

Household, maternal, and other characteristics associated with congenital malaria

Variables Outcome Congenital malaria OR 95% CI P-value
Positive Negative
N (%) N (%)
Household factors Wall type Brick 1 (6.2) 76 (29.5) 0.15 0.02–1.14 0.03
Mud 15 (93.8) 169 (69.0)
Roof type Iron sheet 7 (43.8) 179 (73.3) 0.29 0.10–0.80 0.02
Grass 9 (56.2) 66 (26.9)
Use spray Yes 1 (6.2) 19 (7.8) 0.79 0.10–6.33 0.65
No 15 (93.8) 226 (92.2)
Use of Net Non-ITN 0 (0.0) 4 (1.6) NA NA 0.76
ITN 16 (100.0) 241 (98.4)
Family size < 5 person 9 (56.2) 87 (35.5) 1.07 1.03–1.10 0.08
≥ 5 person 7 (43.8) 158 (64.5)
Maternal factors Malaria treated during pregnancy Quinine 4 (100.0) 24 (32.0) 0.86 0.74–0.10 0.01
Other* 0 (0.0) 51 (68.0)
Chemoprevention during pregnancy IPT-SP 15 (93.8) 239 (97.6) NA NA 0.11
TS 1 (6.2) 0 (0.0)
Both 0 (0.0) 4 (1.6)
None 0 (0.0) 2 (0.80)
Gravidity G1 9 (56.2) 74 (30.2) 2.97 1.07–8.28 0.03
≥ G2 7 (43) 171 (69.8)
Maternal age < 19 years 8 (50.0) 46 (18.8) 4.33 1.54–12.13 0.01
≥ 19 8 (50.0) 199 (81.2)
Level of education Primary 10 (62.5) 152 (62.0) 1.02 0.36–2.90 0.60
Post Primary 6 (37.5) 93 (38.0)
Fever during pregnancy 1st and 2nd trimester 6 (60.0) 71 (81.6) 0.34 0.09–1.34 0.12
3rd trimester 4 (40.0) 16 (18.4)
HIV status during pregnancy Positive 1 (6.2) 6 (2.4) 2.66 0.30–23.50 0.36
Negative 15 (93.8) 239 (97.6)
Maternal malaria at delivery Yes 8 (50.0) 19 (7.8) 11.90 4.02–35.24 0.00
No 8 (50.0) 226 (92.2)
Other factors Placental malaria Yes 3 (75.0) 8 (15.4) 16.50 1.52–179.22 0.02
No 1 (25.0) 44 (84.6)
Cord blood parasitemia Yes 2 (50.0) 1 (2.0) 49.00 3.02–794.52 0.01
No 2 (50.0) 49 (98.0)

ITN = insecticide treated net; SP = sulfadoxine/ pyrimethamine; TS = trimethoprim/sulfamethoxazole. A P-value < 0.05 was considered statistically significant. The bold values in table two show association between congenital malaria and those concerned explanatory variables on binary analysis.

* Other antimalarial drugs included Coartem and Fansidar.